Cardiovascular risk factors in acute coronary syndrome patients undergoing percutaneous coronary intervention in five European countries

被引:0
|
作者
McCollam, P. L.
Nasuti, P.
Bae, J. P.
Smith, H.
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] IMS Hosp Grp Ltd, Sittingbourne, Kent, England
关键词
D O I
10.1016/S1098-3015(10)63619-4
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A337 / A337
页数:1
相关论文
共 50 条
  • [41] Predictive Value of Free Triiodothyronine in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Yang, Zhi Qiang
    Ma, Xiao Teng
    Shao, Qiao Yu
    Li, Qiu Xuan
    Wang, Yu Fei
    Liang, Jing
    Shen, Hua
    Li Liu, Xiao
    Shi, Dong Mei
    Zhou, Yu Jie
    Fang, Zhe
    Wang, Zhi Jian
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (07)
  • [42] Prasugrel or Ticagrelor for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Does it Matter?
    Giri, Jay
    Nathan, Ashwin
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (16) : 1587 - 1589
  • [43] Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Bavishi, Chirag
    Trivedi, Vrinda
    Singh, Mandeep
    Katz, Edward
    Messerli, Franz H.
    Bangalore, Sripal
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (11): : 1325.e1 - 1325.e12
  • [44] Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Wang, Man
    Su, Wen
    Cao, Ning
    Chen, Hui
    Li, Hongwei
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [45] Value of Absolute Eosinophil Count in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Wang, Yufei
    Ma, Xiaoteng
    Yang, Zhiqiang
    Li, Qiuxuan
    Zhou, Yujie
    Gao, Fei
    Wang, Zhijian
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 1025 - 1038
  • [46] Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Man Wang
    Wen Su
    Ning Cao
    Hui Chen
    Hongwei Li
    Cardiovascular Diabetology, 22
  • [47] The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention
    Liao, Jia
    Qiu, Miaohan
    Su, Xiaolin
    Qi, Zizhao
    Xu, Ying
    Liu, Haiwei
    Xu, Kai
    Wang, Xiaozeng
    Li, Jing
    Li, Yi
    Han, Yaling
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [48] Risk factors for repeat percutaneous coronary intervention in young patients (≤45 years of age) with acute coronary syndrome
    Han, Tianwen
    Wang, Qun
    Yang, Huanwan
    Zhou, Shanshan
    Wang, Jing
    Jing, Jing
    Zhang, Tao
    Liu, Yuqi
    Chen, Yundai
    PEERJ, 2019, 7
  • [49] Sleep profile and the risk of cardiovascular events in patients undergoing percutaneous coronary intervention
    Zhu, Chenya
    Lu, Yang
    Cheng, Ming
    Zhou, Zichun
    Zhang, Yuxian
    Lei, Xiaoqing
    Wang, Xiaohua
    Hou, Yunying
    Lu, Minxia
    PSYCHOLOGY HEALTH & MEDICINE, 2023, 28 (03) : 799 - 811
  • [50] Impact of Sex at Birth on Long-Term Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
    Roumeliotis, Anastasios
    Claessen, Bimmer
    Sartori, Samantha
    Cao, Davide
    Qiu, Hanbo
    Camaj, Anton
    Chandiramani, Rishi
    Nicolas, Johny
    Goel, Ridhima
    Chiarito, Mauro
    Sweeny, Joseph
    Dangas, George
    Sharma, Samin
    Kini, Annapoorna
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : B20 - B20